JMP Securities initiated coverage on Kalvista Pharmaceuticals Inc (NASDAQ: KALV), assigning a Market Outperform rating and setting a price target of $19.00. Currently trading at $8.77, the stock has ...

DEI backers, including most top US companies, believe a push for diversity has been good for their businesses.

Activists are calling for a nationwide boycott of Target following the company's decision to roll back its diversity, equity ...